Clinical Trials in Belgium

• The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study Recruiting
  2022-502021-18-00 Phase IV Rheumatoid Arthritis Queen Mary University Of London
• Evaluation of the effectiveness of the reconsolidation therapy in a clinical population suffering from post-traumatic stress disorder Recruiting
  2022-500870-32-02 Phase II Post-traumatic stress disorder Hopital Erasme
• Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting
  2022-501515-14-00 Phase III Newly Diagnosed Multiple Myeloma (NDMM) Celgene Corp.
• Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) Recruiting
  2022-502281-25-00 Phase III Focal Onset Seizures Xenon Pharmaceuticals Inc.
• A Study Evaluating the Overall Survival of Patients with Extensive Stage Small Cell Lung Cancer Receiving Trilaciclib or Placebo prior to To… Recruiting
  2022-502357-34-00 Phase III Extensive Stage Small Cell Lung Cancer Pharmacosmos A/S
• INSTA-MD: INflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder Recruiting
  2022-501692-35-00 Phase III Major Depressive Disorder (MDD) University Of Antwerp
• A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting
  2022-502851-79-00 Phase III Active Idiopathic Inflammatory Myopathy (IIM) Argenx
• A double-blind, placebo-controlled, randomised phase 1/2a study to evaluate the safety, tolerability and pharmacokinetics of single and rep… Recruiting
  2023-505778-14-00 Phase I (FiH) Age related hearing loss Dendrogenix
• A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematologic… Recruiting
  2023-505357-40-00 Phase III Hematological cancer CHU De Liege
• Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes Recruiting
  2022-502082-22-00 Phase III/IV prediabetes UZ Leuven
• A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematop… Recruiting
  2022-501831-18-00 Phase II Patients with hematologic malignancies and undergoing alloge… Maat Pharma
• Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder. Recruiting
  2024-518061-10-00 Phase II Severe Alcohol Use Disorder Association Hospitaliere De Bruxelles Et De Schaerbeek Centre Hospitalier Univer…
• An international randomised trial of radical surgery followed by adjuvant therapy versus no further treatment in patients with early-stage, … Recruiting
  2023-504973-19-01 Phase III early-stage, intermediate-risk cervical cancer CEEGOG z.s.
• MARSUN: Evaluation of the benefits of the combination of Mosunetuzumab-Lenalidomide versus a treatment chosen by the investigator in Patient… Recruiting
  2022-501810-77-00 Phase III Relapsed or Refractory Marginal Zone Lymphoma Lysarc
• Tebentafusp Regimen Versus Investigator’s Choice in Previously Treated Advanced Melanoma (TEBE-AM) Recruiting
  2022-502732-39-00 Phase II/III Previously treated non-ocular advanced melanoma Immunocore Limited
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination with Checkpoint Inhibitor i… Recruiting
  2023-504709-35-00 Phase I Locally advanced or metastatic solid tumors Genentech Inc.
• CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting
  2023-504999-25-00 Phase III Acute Myeloid Leukemia Prinses Maxima Centrum voor Kinderoncologie B.V.
• A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants with Severe Hypertriglyceridemia (SHTG) Recruiting
  2022-501999-26-00 Phase III Severe Hypertriglyceridemia (SHTG) Ionis Pharmaceuticals Inc.
• A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma (RELATIVITY-127) Recruiting
  2022-500967-11-00 Phase III Previously Untreated Metastatic or Unresectable Melanoma Bristol-Myers Squibb Services Unlimited Company
• Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial) Recruiting
  2022-502703-30-00 Phase IV neuroendocrine tumours Antwerp University Hospital
• Pain medication tapering for chronic low back pain patients, treated with an intervention focusing on pain relief for axial problems. Recruiting
  2024-516647-79-00 Phase III/IV Persistent Spinal Pain Syndrome Type II (PSPS T2) Vrije Universiteit Brussel
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma… Recruiting
  2022-501943-34-00 Phase III Alpha-1 Antitrypsin Deficiency-Associated Liver Disease Takeda Development Center Americas Inc.
• A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer Recruiting
  2022-501504-95-00 Phase II Non-metastatic HER2-positive Breast Cancer Karolinska University Hospital
• A study to look at how safe divarasib is when given on its own or in combination with other anti-cancer therapies, and how well these medici… Recruiting
  2023-507171-22-00 Phase I/II Untreated Advanced or Metastatic Non-Small Cell Lung Cancer F. Hoffmann-La Roche AG

Showing 889–912 of 2,369 trials